Header Logo

Connection

Laura Holman to Receptors, Antigen, T-Cell

This is a "connection" page, showing publications Laura Holman has written about Receptors, Antigen, T-Cell.
Connection Strength

0.059
  1. Neoadjuvant or concurrent atezolizumab with chemoradiation for locally advanced cervical cancer: a randomized phase I trial. Nat Commun. 2025 Jan 09; 16(1):553.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.